Q: Is there enough scientific evidence in favor of the radiomics software to justify its use in the care?

Is there enough scientific evidence in favor of the radiomics software to justify its use in the care?

Yes, we believe we have enough scientific evidence that this software is working. Usefulness of the software has been tested in six clinical data sets coming from different centers, comprising imaging data of 930 patients with lung or head and neck cancer. We found a large number of radiomic features, determined by the software, to have strong prognostic power. A multi-feature radiomic signature capturing intra-tumor heterogeneity, was identified and independently validated as being strongly prognostic for overall survival in both lung and head and neck cancer. We believe there are few new molecular biomarkers with such an extensive clinical validation. What makes this approach attractive is that it is non invasive and very cheap because we use existing standard imaging.